Mansueto G, Forzati F, Ferraro A,et al. Identification of a new pathway for tumor progression:？ microRNA-181b up-regulation and CBX7 down-regulation by HMGA1 protein[J]. Genes Cancer, 2010, 1(3):？ 210-224. [2]Deng M, Tang H, Zhou Y,et al. miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma[J]. J Cell Sci, 2011, 124(Pt 17): 2997-3005. [3]Feng R, Chen X, Yu Y,et al. miR-126 functions as a tumour suppressor in human gastric cancer[J]. Cancer Lett, 2010, 298(1): 50-63. [4]Ding L, Xu Y, Zhang W,et al. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2[J]. Cell Res, 2010, 20(7): 784-793. [5]Yan L X, Huang X F, Shao Q,et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis[J]. RNA, 2008, 14(11):？ 2348-2360. [6]Connolly E, Melegari M, Landgraf P,et al. Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype[J]. Am J Pathol, 2008, 173(3): 856-864. [7]Tsai W C, Hsu S D, Hsu C S,et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis [J]. J Clin Invest, 2012, 122(8):？ 2884-2897. [8]Sheng Y, Ding S, Chen K,et al. Functional analysis of miR-101-3p and Rap1b involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis[J]. Biochem Cell Biol, 2014, 92(2): 152-162. [9]Inohara N, Koseki T, Hu Y,et al. CLARP, a death effecter domain-containing protein interacts with caspase-8 and regulates apoptosis[J]. Proc Natl Acad Sci U S A, 1997, 94(20): 10717-10722 [10]Day T W, Huang S, Safa A R. c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells[J]. Biochem Pharmacol, 2008, 76(12):？ 1694-1704. [11]Li Z, Zhang J, Chen D,et al. Casper/c-FLIP is physically and functionally associated with NF-kappaB1 p105[J]. Biochem Biophys Res Commun, 2003, 309(4): 980-985. [12]Lin Z, Flemington E K. miRNAs in the pathogenesis of oncogenic human viruses[J]. Cancer Lett, 2011, 305(2):？ 186-199. [13]Xu X, Fan Z, Kang L,et al. Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis[J]. J Clin Invest, 2013, 123(2):？ 630-645. [14]Wang C M, Wang Y, Fan C G,et al. miR-29c targets TNFAIP3, inhibits cells proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma[J]. Biochem Biophys Res Commun, 2011, 411(3):？ 586-592. [15]Zhang Z Z, Liu X, Wang D Q,et al. Hepatitis B virus and hepatocellular carcinoma at the mRNA level[J]. Word J Gastroenterol, 2011, 17(28):？ 3353-3358. [16]Michael M Z, O' Connor S M, van-Holst-Pellekaan N G,et al. Reduced accumulation of specific microRNAs in colorectal neoplasia[J]. Mol Cancer Res, 2003, 1(12):？ 882-891. [17]Hayashita Y, Osada H, Tatematsu Y,et al. A polycistronic MicroRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation[J]. Cancer Res, 2005, 65(21):？ 9628-9632. [18]Harfe B D. MicroRNAs in vertebrate development[J]. Curr Opin Genet Dev, 2005, 15(4): 410-415. [19]Tong A W, Nemunaitis J. Modulation of miRNA activity in human cancer:？ a new paradigm for cancer gene therapy[J]. Cancer Gene Ther, 2008, 15(6): 341-355. [20]Hou Y Y, Lee J H, Chen H C,et al. The association between miR-499a polymorphism and oral squamous cell carcinoma progression[J]. Oral Dis, 2014, [Epub ahead of print]. [21]Ma Y, Wang R, Zhang J,et al. Identification of miR-423 and miR-499 polymorphisms on affecting the risk of hepatocellular carcinoma in a large-scale population[J]. Genet Test Mol Biomarkers, 2014, 18(7):？ 516-524. ？
